Jain Global »

Cartesian Therapeutics shares owned by Jain Global

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Jain Global from 13F filings

Historical chart of Jain Global investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Jain Global consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Jain Global

Quarter filed Position value Share count Share price at filing
2025-12-31 $121k 17k 7.21

More positions owned by Jain Global

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tesla Motors (TSLA)
Boeing Company (BA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Jain Global

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Vanguard Group
683 Capital Management
Erste Asset Management GmbH
Geode Capital Management
State Street Corporation
Marshall Wace
Privium Fund Management B.V.
Jacobs Levy Equity Management
Northern Trust
Citadel Advisors
GSA Capital Partners
UBS Group
Susquehanna International

View all funds holding Cartesian Therapeutics